LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.
about
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationLymphocyte-activation gene-3, an important immune checkpoint in cancerTransplantation Tolerance Induction: Cell Therapies and Their MechanismsBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsTransplantation tolerance and its outcome during infections and inflammationCostimulatory pathways in transplantation.Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier.Memory T cells and their exhaustive differentiation in allograft tolerance and rejection.TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant toleranceCD8+ T cell exhaustion during persistent viral infection is regulated independently of the virus-specific T cell receptor.PD-1 coinhibitory signals: the link between pathogenesis and protection.Induction of tolerance through mixed chimerism.Self-reactivity as the necessary cost of maintaining a diverse memory T-cell repertoire.Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.Layers of regulation in induction of mixed chimerism by anti-CD40L.Mechanisms of Mixed Chimerism-Based Transplant Tolerance.Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade.
P2860
Q21132345-06CC6BA9-FABE-4EDF-B7CB-2D75BF85E88AQ26746209-4BF01370-18B7-4CD3-A964-93BE7B638EE2Q26751022-9E1079D9-58CB-4A6D-B300-6F7E2913C0A1Q26782799-E25DB8ED-7317-4283-BC20-1C6788E5761AQ26829817-A7B3151F-21BF-4513-8608-07322EDC9FB2Q34187594-B0E0FD2F-4301-4C4E-9940-319892D4BD2DQ34779037-934A4900-7D49-440F-9379-090FD36A69D9Q35023283-6B7AB7D1-4F9A-4112-8C89-A94D8D38C8AAQ36095846-1366E2FF-B9FB-4CE1-98C4-743882DD3C80Q36568502-96B04EE9-5315-4883-A6D2-F60E977B78D0Q36677821-4AF7C730-F8B7-4AAC-8790-7F1295D972DEQ38095246-F193ABDA-2029-4472-8D7E-9D99882261ABQ38175306-3FF8C264-55FC-43CA-ABD2-D10A53FF763AQ38952548-A55C498B-26FF-4880-8B1F-78B537B6A384Q39313794-AD668F77-5E18-4111-BF4D-131E3F292BADQ42083190-6A85A73D-6153-4D12-8DF1-BA676DC7EA4BQ53102364-2CE69918-0EA9-4334-8CE3-1753EB72339FQ54283965-9B11625E-67B6-4AAF-852A-3F7591CA9E31
P2860
LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@ast
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@en
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@nl
type
label
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@ast
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@en
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@nl
prefLabel
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@ast
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@en
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@nl
P2093
P2860
P1433
P1476
LAG-3, TGF-β, and cell-intrins ...... llogeneic BMT with anti-CD40L.
@en
P2093
Carrie L Lucas
Creg J Workman
Dario A A Vignali
Guiling Zhao
Megan Sykes
Samuel LoCascio
Semir Beyaz
P2860
P304
P356
10.1182/BLOOD-2010-11-318675
P407
P577
2011-03-21T00:00:00Z